146 related articles for article (PubMed ID: 3533554)
1. Limitations of the salmonella/mammalian microsome assay (Ames test) to determine occupational exposure to cytostatic drugs.
Friederich U; Molko F; Hofmann V; Scossa D; Hann D; Würgler FE; Senn HJ
Eur J Cancer Clin Oncol; 1986 May; 22(5):567-75. PubMed ID: 3533554
[TBL] [Abstract][Full Text] [Related]
2. [Urinary excretion of mutagens and cisplatin among the nursing staff at a medical oncology department exposed to cytostatic drugs].
Clonfero E; Granella M; Gori GP; Venier P; Levis AG; Morandi P; Bartolucci GB; Saia B
Med Lav; 1989; 80(5):412-9. PubMed ID: 2622413
[TBL] [Abstract][Full Text] [Related]
3. Limitations of urinary mutagen assays for monitoring occupational exposure to antineoplastic drugs.
Tuffnell PG; Gannon MT; Dong A; DeBoer G; Erlichman C
Am J Hosp Pharm; 1986 Feb; 43(2):344-8. PubMed ID: 3513557
[TBL] [Abstract][Full Text] [Related]
4. The mutagenicity of urine fractions from patients administered antineoplastic therapy.
Monteith DK; Connor TH; Benvenuto JA; Fairchild EJ; Theiss JC
Toxicol Lett; 1988 Mar; 40(3):257-68. PubMed ID: 3354010
[TBL] [Abstract][Full Text] [Related]
5. Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials.
DeMéo MP; Mérono S; DeBaille AD; Botta A; Laget M; Guiraud H; Duménil G
Int Arch Occup Environ Health; 1995; 66(6):363-8. PubMed ID: 7782118
[TBL] [Abstract][Full Text] [Related]
6. Risk of handling injectable antineoplastic agents.
Anderson RW; Puckett WH; Dana WJ; Nguyen TV; Theiss JC; Matney TS
Am J Hosp Pharm; 1982 Nov; 39(11):1881-7. PubMed ID: 6756133
[TBL] [Abstract][Full Text] [Related]
7. Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking.
Bos RP; Leenaars AO; Theuws JL; Henderson PT
Int Arch Occup Environ Health; 1982; 50(4):359-69. PubMed ID: 6757139
[TBL] [Abstract][Full Text] [Related]
8. Stability and inactivation of mutagenic drugs and their metabolites in the urine of patients administered antineoplastic therapy.
Monteith DK; Connor TH; Benvenuto JA; Fairchild EJ; Theiss JC
Environ Mol Mutagen; 1987; 10(4):341-56. PubMed ID: 3315656
[TBL] [Abstract][Full Text] [Related]
9. Detection of mutagenic activity in human urine using mutant strains of Salmonella typhimurium.
Minnich V; Smith ME; Thompson D; Kornfeld S
Cancer; 1976 Sep; 38(3):1253-8. PubMed ID: 782687
[TBL] [Abstract][Full Text] [Related]
10. Urinary mutagenicity assays: a problem arising from the presence of histidine associated growth factors in XAD-2 prepared urine concentrates, with particular relevance to assays carried out using the bacterial fluctuation test.
Gibson JF; Baxter PJ; Hedworth-Whitty RB; Gompertz D
Carcinogenesis; 1983 Nov; 4(11):1471-6. PubMed ID: 6357523
[TBL] [Abstract][Full Text] [Related]
11. Concentration of mutagens from urine by absorption with the nonpolar resin XAD-2: cigarette smokers have mutagenic urine.
Yamasaki E; Ames BN
Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3555-9. PubMed ID: 333441
[TBL] [Abstract][Full Text] [Related]
12. Biomonitoring of urine mutagenicity with the Ames test: improvement of the extraction/concentration method.
Andre V; Lebailly P; Deslandes E; Henry-Amar M; Gauduchon P
Mutat Res; 2002 Sep; 520(1-2):199-205. PubMed ID: 12297160
[TBL] [Abstract][Full Text] [Related]
13. Handling of cytostatic drugs and urine mutagenesis.
Poyen D; De Méo MP; Botta A; Gouvernet J; Duménil G
Int Arch Occup Environ Health; 1988; 61(3):183-8. PubMed ID: 3220590
[TBL] [Abstract][Full Text] [Related]
14. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test.
Benedict WF; Baker MS; Haroun L; Choi E; Ames BN
Cancer Res; 1977 Jul; 37(7 Pt 1):2209-13. PubMed ID: 193638
[TBL] [Abstract][Full Text] [Related]
15. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
[TBL] [Abstract][Full Text] [Related]
16. The use of rat urine extracted on XAD-2 resin and assayed in a microsuspension-modified Ames test as an in vivo indicator of genotoxic exposure.
Doolittle DJ; Lee DA; Rahn CA
Mutat Res; 1988 Oct; 206(2):141-8. PubMed ID: 3050496
[TBL] [Abstract][Full Text] [Related]
17. The mutagenic activity of anti-cancer drugs and the urine of rats given these drugs.
Pak K; Iwasaki T; Miyakawa M; Yoshida O
Urol Res; 1979 Jun; 7(2):119-24. PubMed ID: 382571
[TBL] [Abstract][Full Text] [Related]
18. Mutagenicity of cytostatic drugs in a bacterial system. I. Ames test.
Marhan J
Folia Microbiol (Praha); 1995; 40(5):457-61. PubMed ID: 8763144
[TBL] [Abstract][Full Text] [Related]
19. The urine mutagenicity assay system. Studies related to recovery, storage and concentration procedures.
Ong TM; Stockhausen A; Adamo D; Whong WZ
Scand J Work Environ Health; 1985 Feb; 11(1):45-50. PubMed ID: 3992221
[TBL] [Abstract][Full Text] [Related]
20. Detection of low levels of urinary mutagen excretion by chemotherapy workers which was not related to occupational drug exposures.
Everson RB; Ratcliffe JM; Flack PM; Hoffman DM; Watanabe AS
Cancer Res; 1985 Dec; 45(12 Pt 1):6487-97. PubMed ID: 4063994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
